Tubingen, Germany

Paolo Macchi

USPTO Granted Patents = 2 


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paolo Macchi: Innovator in Pharmaceutical Composition

Introduction

Paolo Macchi is a notable inventor based in Tubingen, Germany. He has made significant contributions to the field of pharmaceutical compositions, particularly in relation to nervous tissue and cardiovascular disorders. With a total of 2 patents, his work has the potential to impact various medical conditions.

Latest Patents

Macchi's latest patents include innovative approaches to treating diseases associated with the degeneration or injury of vertebrate nervous tissue. One patent focuses on the use of a modulator of a polypeptide for the preparation of a pharmaceutical composition aimed at preventing, alleviating, or treating conditions related to seizures and angiogenic disorders. Another patent emphasizes the therapeutic use of antibodies directed against repulsive guidance molecule (RGM), which also targets similar medical conditions and tumor growth.

Career Highlights

Paolo Macchi is affiliated with the Max Planck Society for the Advancement of Science, a prestigious research institution known for its contributions to various scientific fields. His work at this institution has allowed him to explore and develop groundbreaking pharmaceutical solutions.

Collaborations

Macchi has collaborated with esteemed colleagues such as Bernhard K. Mueller and Philippe Patrick Monnier. These partnerships have further enriched his research and innovation in the pharmaceutical domain.

Conclusion

Paolo Macchi's contributions to the field of pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of research in addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…